Guidance: Oral health management of patients prescribed bisphosphonates

Assorted pills

Patients taking bisphosphonates are at increased risk of oral health complications (Bisphosphonate-related Osteonecrosis of the Jaw – BONJ).

BONJ is defined as exposed, necrotic bone in the maxilla or mandible that has persisted for more than eight weeks in patients taking bisphosphonates and where there has been no history of radiation therapy to the jaw.

Symptoms include:

  • delayed healing following a dental extraction or other oral surgery
  • pain
  • soft tissue infection and swelling
  • numbness
  • paraesthesia
  • exposed bone.

Dentists are increasingly likely to see patients taking bisphosphonates because these drugs are being prescribed more often to prevent as well as to treat a wider variety of medical conditions.

This guidance has been developed by a mulidisciplinary team working with the Scottish Dental Clinical Effectiveness Programme.

The guidance document and patient advice leaflet can be downloaded from the Bisphosphonate page of the SDCEP ( Scottish Clinical Effectiveness Programme) website.

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Profile photo of Derek Richards

Derek Richards

Derek Richards is the Director of the Centre for Evidence-based Dentistry, Editor of the Evidence-based Dentistry Journal, Consultant in Dental Public Health with Forth Valley Health Board and Honorary Senior Lecturer at Dundee & Glasgow Dental Schools. He helped to establish both the Centre for Evidence-based Dentistry and the Evidence-based Dentistry Journal. He has been involved with teaching EBD and a wide range of evidence-based initiatives both nationally and internationally since 1994.

More posts - Website

Follow me here –